Sulnidazole
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101687This classification denotes an antiprotozoal agent with the molecular formula C9H14N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 504LR309YV, chemically known as r 26,412 but generally known as sulnidazole, which bears US NIH Compound Identifier 3037172. European Medicines Agency schedules Sulnidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10750MIG. The term SULNIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). SULNIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulnidazole under HS 29332990 and SITC 51573. As of Q4 2014, SULNIDAZOLE remains the US FDA Preferred Term for this commodity. Sulnidazole bears US NLM identifiers UMLS ID C2348602 and NCI Concept Code C73278. SMILES: S=C(OC)NCCN1C(NCC1[N](=O)O)CC.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.